Tag

COVID19 clinical trial

TRHC Launches First Large Simulation Study to Assess Adverse Drug Events with proposed COVID-19 Treatments

Moorestown, NJ, April 29, 2020 – Tabula Rasa HealthCare Corporation® (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announced today it is running a clinical study assessing the risk of adverse drug events (ADEs) associated with drugs repurposed for the treatment of COVID-19 in older adults on multiple medications. “This study showcases the depth and breadth of our clinical research capabilities,” said TRHC Chairman and CEO Calvin H. Knowlton, PhD. “The... Read More